EKF Diagnostics Holdings plc Stock

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Delayed London S.E. 09:19:19 2024-04-16 am EDT 5-day change 1st Jan Change
28 GBX -1.58% Intraday chart for EKF Diagnostics Holdings plc +0.72% -11.53%
Sales 2023 52.61M 65.38M Sales 2024 * 55.49M 68.96M Capitalization 129M 160M
Net income 2023 2M 2.49M Net income 2024 * 4M 4.97M EV / Sales 2023 2.66 x
Net cash position 2023 3.63M 4.51M Net cash position 2024 * 9.78M 12.15M EV / Sales 2024 * 2.15 x
P/E ratio 2023
60.9 x
P/E ratio 2024 *
30.3 x
Employees 356
Yield 2023
3.79%
Yield 2024 *
4.22%
Free-Float 94.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.53%
1 week+3.08%
Current month+3.08%
1 month+7.77%
3 months-9.39%
6 months+2.34%
Current year-10.11%
More quotes
1 week
27.00
Extreme 27
28.90
1 month
23.00
Extreme 23
29.70
Current year
23.00
Extreme 23
34.00
1 year
22.20
Extreme 22.2
38.22
3 years
22.20
Extreme 22.2
86.80
5 years
16.58
Extreme 16.5794
86.80
10 years
7.00
Extreme 7
86.80
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 23-09-11
- -
Members of the board TitleAgeSince
Director/Board Member 72 16-04-07
Director/Board Member 49 21-06-30
Director/Board Member 64 22-01-31
More insiders
Date Price Change Volume
24-04-16 28 -1.58% 37 270
24-04-15 28.45 +0.53% 54,120
24-04-12 28.3 +1.98% 38,602
24-04-11 27.75 +1.09% 195,053
24-04-10 27.45 -1.26% 289,400

Delayed Quote London S.E., April 15, 2024 at 11:35 am EDT

More quotes
EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.2845 GBP
Average target price
0.3333 GBP
Spread / Average Target
+17.16%
Consensus